Deutetrabenazine

AUSTEDO, AUSTEDO XR

NADAC/unit $83.5114

No Shortage Tier 1: 207.9% PA Req: 1046.2%

AUSTEDO XR ® and AUSTEDO ® are indicated in adults for the treatment of: chorea associated with Huntington’s disease [see Clinical Studies ( 14.1 )] tardive dyskinesia [see Clinical Studies ( 14.2 ....

vs. brand AUSTEDO: Generic saves up to -735% per unit

Covered Lives

Generic Manufacturers

TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLCTEVA NEUROSCIENCE INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Deutetrabenazine drfinder.aiFind doctors who prescribe Deutetrabenazine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Deutetrabenazine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.